Jingze_Providing professional financial news and data related to Jingze, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Jingze Biopharmaceutical (Hefei) Co., Ltd. Makes Third HKEX Listing Filing, CICC and Guoyuan International Act as Joint Sponsors

Tags：

Jingze IPO file a listing application

2026-07-06

Finance
Honghua Group Limited (00196.HK): Profit Warning, Expected Interim Loss of RMB 20 Million to RMB 40 Million
Finance
Greater China Financial (00431.HK): Cancellation of Listing Status
Finance
STERLING GP (01825.HK): Receives Early Repayment, Remaining Outstanding Principal Approximately HK$105,000
Finance
Blue River Holdings (00498.HK): Expects to Turn Loss Into Profit for the Year, Recording Profit of Approximately HK$51 Million
Finance
Shenzhen International (00152.HK): Completes Issuance of Phase 2 2026 Medium-Term Notes Worth RMB 2 Billion
ETF
Value Gold ETF (03081.HK) Slips 0.71% Intraday, Turnover Hits HK$4.0832 Million
ETF
Csop Nikkei 225 Daily (-2x) Inverse Product(07515.HK) Drops 0.55% Intraday with NAV Per Unit at HK$12.577
ETF
Ishares Nasdaq 100 Index Etf(02834.HK) Falls 0.32% Intraday with NAV Per Unit at HK$561.906
ETF
Invesco Qqq Trust(03455.HK) Slips 0.12% Intraday with Turnover of HK$4.3378 Million
ETF
E Fund (HK) CSI Liquor Index ETF(03189.HK) Rises 0.74% Intraday at HK$1.082

Scan QR Code

Download App